Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.6B | 2.6B | 2.6B | 2.6B |
Cost of revenue | 723M | 718M | 727M | 735M |
Gross profit | 1.9B | 1.9B | 1.8B | 1.8B |
Operating expense | ||||
Research & development | 362M | 375M | 374M | 379M |
Selling general and admin | 797M | 850M | 786M | 818M |
Other operating expenses | 81M | 87M | 89M | 86M |
Operating income | 616M | 543M | 595M | 549M |
Non operating interest income | ||||
Income | 77M | 76M | 72M | 63M |
Expense | 61M | 65M | 63M | 65M |
Other income expense | 2M | 63M | 193M | -219M |
Pretax income | 634M | 617M | 797M | 328M |
Tax provision | 129M | -63M | 161M | 102M |
Net income | 503M | 679M | 634M | 224M |
Basic EPS | 1.1 | 1.4 | 1.3 | 0.5 |
Diluted EPS | 1.1 | 1.4 | 1.3 | 0.5 |
Basic average shares | 398.2K | 406.7K | 415.3K | 428.9K |
Diluted average shares | 405.0K | 413.6K | 421.2K | 432.3K |
EBITDA | 772M | 698M | 759M | 689M |
Net income from continuing op. | 505M | 680M | 636M | 226M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |